无细胞百日咳疫苗：路在何方？ - Suppr

Suppr

超能文献

Acellular pertussis vaccines: where to go to?

作者信息

von König Carl Heinz Wirsing

机构信息

Labor:Medizin Krefeld MVZ, Krefeld 47805, Germany.

出版信息

Lancet Infect Dis. 2018 Jan;18(1):5-6. doi: 10.1016/S1473-3099(17)30613-8. Epub 2017 Oct 20.

DOI:10.1016/S1473-3099(17)30613-8

PMID:29066129

Abstract

摘要

相似文献

Acellular pertussis vaccines: where to go to?无细胞百日咳疫苗：路在何方？

Lancet Infect Dis. 2018 Jan;18(1):5-6. doi: 10.1016/S1473-3099(17)30613-8. Epub 2017 Oct 20.

[THE COMBINATION OF TRIPLE ANTIGEN (PERTUSSIS-DIPHTHERIA-TETANUS) AND ANTIPOLIOMYELITIS VACCINATION IN THE INFANT].[婴儿接种三联抗原（百日咳-白喉-破伤风）与脊髓灰质炎疫苗的联合接种]

Ann Paediatr. 1963;201:95-107.

An approach to establishing diphtheria potency specifications for diphtheria and tetanus toxoid, acellular pertussis vaccine formulations linked to clinical efficacy.

Biologicals. 1999 Jun;27(2):183. doi: 10.1006/biol.1999.0206.

Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(®)): results of two randomized trials.65 岁及以上成年人接种破伤风类毒素、白喉类毒素和无细胞百日咳疫苗（Boostrix(®)）：两项随机试验的结果。

Vaccine. 2012 Feb 21;30(9):1721-8. doi: 10.1016/j.vaccine.2011.12.055. Epub 2011 Dec 31.

[HEMOLYTIC-UREMIC SYNDROMES FOLLOWING TRIPLE VACCINATION (DIPHTHERIA-PERTUSSIS-TETANUS)].三联疫苗（白喉-百日咳-破伤风）接种后出现的溶血性尿毒症综合征

Arch Pediatr Urug. 1965 Jan;36:26-38.

Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.在韩国，一项比较联合使用无细胞百白破、灭活脊髓灰质炎（DTaP-IPV）疫苗与分别单独使用百白破（DTaP）和脊髓灰质炎（IPV）疫苗的免疫原性和安全性的随机对照研究：在婴儿中进行的研究。

Vaccine. 2011 Feb 11;29(8):1551-7. doi: 10.1016/j.vaccine.2010.12.094. Epub 2011 Jan 6.

[STATISTICO-CLINICAL DATA ON THE USE OF THE COMBINED DIPHTHERIA-PERTUSSIS-TETANUS-POLIOVIRUS VACCINE IN INFANTS].[关于婴儿使用白喉-百日咳-破伤风-脊髓灰质炎联合疫苗的统计临床数据]

Pediatria (Napoli). 1963;71:962-7.

Vaccination in infancy with oral poliomyelitis vaccine and diphtheria, tetanus, pertussis vaccine.婴儿期口服脊髓灰质炎疫苗以及白喉、破伤风、百日咳疫苗的接种。

Br Med J. 1963 Mar 9;1(5331):641-3. doi: 10.1136/bmj.1.5331.641.

Update on the supply of tetanus and diphtheria toxoids and of diphtheria and tetanus toxoids and acellular pertussis vaccine.破伤风类毒素和白喉类毒素以及白喉破伤风类毒素和无细胞百日咳疫苗供应情况的最新信息。

MMWR Morb Mortal Wkly Rep. 2001 Mar 16;50(10):189-90.

Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.联合低抗原含量白喉-破伤风-无细胞百日咳和脊髓灰质炎疫苗（dTpa-IPV）用于成人加强免疫接种。

Vaccine. 2005 May 25;23(28):3657-67. doi: 10.1016/j.vaccine.2005.02.013.

引用本文的文献

Antiviral responses induced by Tdap-IPV vaccination are associated with persistent humoral immunity to Bordetella pertussis.Tdap-IPV 疫苗接种诱导的抗病毒反应与对百日咳博德特氏菌的持久体液免疫有关。

Nat Commun. 2024 Mar 8;15(1):2133. doi: 10.1038/s41467-024-46560-w.

Association between the COVID-19 pandemic and pertussis derived from multiple nationwide data sources, France, 2013 to 2020.2013 年至 2020 年法国多个全国性数据源中 COVID-19 大流行与百日咳之间的关联。

Euro Surveill. 2022 Jun;27(25). doi: 10.2807/1560-7917.ES.2022.27.25.2100933.

Duration of Immunity and Effectiveness of Diphtheria-Tetanus-Acellular Pertussis Vaccines in Children.儿童白喉-破伤风-无细胞百日咳疫苗的免疫持续时间和有效性。

JAMA Pediatr. 2019 Jun 1;173(6):588-594. doi: 10.1001/jamapediatrics.2019.0711.

Neonatal Immunity to Infection and Current Prevention Strategies.新生儿抗感染免疫及当前预防策略。

J Immunol Res. 2019 Feb 10;2019:7134168. doi: 10.1155/2019/7134168. eCollection 2019.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验